Literature DB >> 17363312

PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation.

Kenichi Yamane1, Keisuke Tateishi, Robert J Klose, Jia Fang, Laura A Fabrizio, Hediye Erdjument-Bromage, Joyce Taylor-Papadimitriou, Paul Tempst, Yi Zhang.   

Abstract

Posttranslational modification of chromatin by histone methylation has wide-ranging effects on nuclear function, including transcriptional regulation, maintenance of genome integrity, and epigenetic inheritance. The enzymes utilized to place histone methylation marks are well characterized, but the identity of a histone demethylation system remained elusive until recently. The discovery of histone demethylase enzymes capable of directly removing methyl groups from modified lysine residues has demonstrated that histone methylation is a dynamic modification. The most extensive family of histone demethylase enzymes identified so far contains a JmjC domain and catalyzes demethylation through a hydroxylation reaction. Here, we identify PLU-1, a transcriptional repressor implicated in breast cancer, as a histone demethylase enzyme that has the ability to reverse the trimethyl H3K4 modification state. Furthermore, we reveal that PLU-1-mediated H3K4 demethylase activity plays an important role in the proliferative capacity of breast cancer cells through repression of tumor suppressor genes, including BRCA1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363312     DOI: 10.1016/j.molcel.2007.03.001

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  209 in total

1.  The JmjN domain of Jhd2 is important for its protein stability, and the plant homeodomain (PHD) finger mediates its chromatin association independent of H3K4 methylation.

Authors:  Fu Huang; Mahesh B Chandrasekharan; Yi-Chun Chen; Srividya Bhaskara; Scott W Hiebert; Zu-Wen Sun
Journal:  J Biol Chem       Date:  2010-06-09       Impact factor: 5.157

Review 2.  Chemical and biochemical approaches in the study of histone methylation and demethylation.

Authors:  Keqin Kathy Li; Cheng Luo; Dongxia Wang; Hualiang Jiang; Y George Zheng
Journal:  Med Res Rev       Date:  2012-07       Impact factor: 12.944

3.  Activity of a C-terminal plant homeodomain (PHD) of Msc1 is essential for function.

Authors:  Xinxing Qiu; Barbara E Dul; Nancy C Walworth
Journal:  J Biol Chem       Date:  2010-09-21       Impact factor: 5.157

4.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

5.  Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A.

Authors:  Toru Sengoku; Shigeyuki Yokoyama
Journal:  Genes Dev       Date:  2011-10-14       Impact factor: 11.361

6.  Histone demethylase RBP2 is critical for breast cancer progression and metastasis.

Authors:  Jian Cao; Zongzhi Liu; William K C Cheung; Minghui Zhao; Sophia Y Chen; Siew Wee Chan; Carmen J Booth; Don X Nguyen; Qin Yan
Journal:  Cell Rep       Date:  2014-02-27       Impact factor: 9.423

Review 7.  Developmental roles of the histone lysine demethylases.

Authors:  Amanda Nottke; Mónica P Colaiácovo; Yang Shi
Journal:  Development       Date:  2009-03       Impact factor: 6.868

8.  Cofactors-loaded quaternary structure of lysine-specific demethylase 5C (KDM5C) protein: Computational model.

Authors:  Yunhui Peng; Emil Alexov
Journal:  Proteins       Date:  2016-10-01

9.  Lid2 is required for coordinating H3K4 and H3K9 methylation of heterochromatin and euchromatin.

Authors:  Fei Li; Maite Huarte; Mikel Zaratiegui; Matthew W Vaughn; Yang Shi; Rob Martienssen; W Zacheus Cande
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

10.  KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.

Authors:  Guoliang Li; Thanigaivelan Kanagasabai; Wenfu Lu; Mike R Zou; Shang-Min Zhang; Sherly I Celada; Michael G Izban; Qi Liu; Tao Lu; Billy R Ballard; Xinchun Zhou; Samuel E Adunyah; Robert J Matusik; Qin Yan; Zhenbang Chen
Journal:  Cancer Res       Date:  2020-08-31       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.